Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryoichi Ando

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Nephrology|June 27, 2016
The use of vitamin D analogs is independently associated with the favorable renal prognosis in chronic kidney disease stages 4-5: the CKD-ROUTE studyYohei Arai, Eiichiro Kanda, Soichiro Iimori, et al.
Journal of Inflammation (London, England)|May 16, 2012
Effect of erythropoietin-stimulating agent on uremic inflammationYuri Tanaka, Nobuhiko Joki, Hiroki Hase, et al.
Clinical and Experimental Nephrology|September 14, 2011
Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patientsFumihiko Koiwa, Daisuke Komukai, Makoto Hirose, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 24, 2014
Multicenter study on the long-term (3-year) efficacy of lanthanum carbonate in dialysis patientsRyoichi Ando, Satomi Yama, Tsuyoshi Ohnishi, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 3, 2023
Efficacy of molnupiravir and sotrovimab in Japanese dialysis patients with COVID-19 in clinical practice during the Omicron (BA.1 and BA.2) pandemicKan Kikuchi, Masaomi Nangaku, Munekazu Ryuzaki, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 24, 2022
Effectiveness of SARS-CoV-2 vaccines on hemodialysis patients in Japan: A nationwide cohort studyKan Kikuchi, Masaomi Nangaku, Munekazu Ryuzaki, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 22, 2015
Possible prevention of dialysis-requiring congestive heart failure by angiotensin-II receptor blockers in non-dialysis Japanese patients with Stage 5 chronic kidney diseaseMasato Ikeda, Masatsugu Nakao, Keita Hirano, et al.
Medicine|November 20, 2025
Current tuberculosis status and challenges among dialysis patients in Japan: A nationwide cross-sectional surveyAyumi Yoshifuji, Kan Kikuchi, Ryoichi Ando, et al.
Clinical and Experimental Nephrology|November 16, 2016
Possible prevention of uremic nausea by vitamin D receptor activators in non-dialysis patients with stage 5 chronic kidney diseaseMasato Ikeda, Yoshimi Ueda, Yukio Maruyama, et al.
Cardiorenal Medicine|March 5, 2015
Association between the Hemoglobin Level and Cardiothoracic Ratio in Patients on Incident DialysisTakasuke Asakawa, Nobuhiko Joki, Yuri Tanaka, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Nephrology|June 27, 2016
The use of vitamin D analogs is independently associated with the favorable renal prognosis in chronic kidney disease stages 4-5: the CKD-ROUTE studyYohei Arai, Eiichiro Kanda, Soichiro Iimori, et al.
Journal of Inflammation (London, England)|May 16, 2012
Effect of erythropoietin-stimulating agent on uremic inflammationYuri Tanaka, Nobuhiko Joki, Hiroki Hase, et al.
Clinical and Experimental Nephrology|September 14, 2011
Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patientsFumihiko Koiwa, Daisuke Komukai, Makoto Hirose, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 24, 2014
Multicenter study on the long-term (3-year) efficacy of lanthanum carbonate in dialysis patientsRyoichi Ando, Satomi Yama, Tsuyoshi Ohnishi, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 3, 2023
Efficacy of molnupiravir and sotrovimab in Japanese dialysis patients with COVID-19 in clinical practice during the Omicron (BA.1 and BA.2) pandemicKan Kikuchi, Masaomi Nangaku, Munekazu Ryuzaki, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 24, 2022
Effectiveness of SARS-CoV-2 vaccines on hemodialysis patients in Japan: A nationwide cohort studyKan Kikuchi, Masaomi Nangaku, Munekazu Ryuzaki, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 22, 2015
Possible prevention of dialysis-requiring congestive heart failure by angiotensin-II receptor blockers in non-dialysis Japanese patients with Stage 5 chronic kidney diseaseMasato Ikeda, Masatsugu Nakao, Keita Hirano, et al.
Medicine|November 20, 2025
Current tuberculosis status and challenges among dialysis patients in Japan: A nationwide cross-sectional surveyAyumi Yoshifuji, Kan Kikuchi, Ryoichi Ando, et al.
Clinical and Experimental Nephrology|November 16, 2016
Possible prevention of uremic nausea by vitamin D receptor activators in non-dialysis patients with stage 5 chronic kidney diseaseMasato Ikeda, Yoshimi Ueda, Yukio Maruyama, et al.
Cardiorenal Medicine|March 5, 2015
Association between the Hemoglobin Level and Cardiothoracic Ratio in Patients on Incident DialysisTakasuke Asakawa, Nobuhiko Joki, Yuri Tanaka, et al.
Pageof 4